pharmacy technician - Ontario College of Pharmacists

LAWS & REGULATIONS
Drug and Pharmacies Regulation Act (DPRA) * s
March 14, 2011
Regulations to the DPRA:
Regulation 58/11
Drug Schedules **
Summary of Laws
June 2007 OCP
National Drug Schedules (NAPRA)
April 20, 2011 (or later)
Scheduling Finalized – Naproxen 220mg
Naproxen sodium 220 mg per oral dosage unit (when sold in products
labeled with a recommended maximum daily dose of 440 mg, and in
package sizes exceeding 6,600 mg) – Schedule III (from Schedule II) was
finalized effective April 21, 2011. Final approval of the initial recommendation
was made by NAPRA’s Executive Committee, in consideration of
comments received during the 30-day review period. The National Drug
Schedules will be revised accordingly.
Regulated Health Professions Act (RHPA) * s
October 25, 2010
Regulations to the RHPA:
Regulation 39/02 – Amended to O.Reg. 666/05
Regulation 107/96 – Amended to O.Reg. 97/10
Regulation 59/94 – Funding for Therapy or Counseling for Patients
Sexually Abused by Members
Pharmacy Act (PA) & Regulations * s
December 3, 2010
Regulations to the PA:
Regulation 202/94 Amended to O.Reg. 59/11
Regulation 681/93 Amended to O.Reg. 122/97
Standards of Practice s
Model Standards of Practice, 2010
Standards for Pharmacists Providing Services to Licensed
LTC Facilities, 2007
Drug Interchangeability and Dispensing Fee Act (DIDFA) &
Regulations * s
May 18, 2010
Regulations to the DIDFA:
Regulation 935 Amended to O.Reg. 221/10
Regulation 936 Amended to O.Reg. 205/96
Ontario Drug Benefit Act (ODBA) & Regulations * s
July 1, 2010
Regulations to the ODBA:
Regulation 201/96 Amended to O.Reg. 220/10
Controlled Drugs and Substances Act (CDSA) & Regulations ** '
Act current to March 24, 2011
All regulations current to March 22, 2011
Benzodiazepines and Other Targeted Substances Regulations
Marihuana Medical Access Regulations
Narcotic Control Regulations
Precursor Control Regulations
Regulations Exempting Certain Precursors and Controlled Substances from
the Application of the Controlled Drugs and Substances Act
Food and Drugs Act (FDA) & Regulations ** '
Act current to March 24, 2011
All regulations current to March 22, 2011
Cosmetic Regulations
Food and Drug Regulations
Marijuana Exemption (FDA) Regulations
Medical Devices Regulations
Natural Health Products Regulations
Processing and Distribution of Semen for Assisted Conception Regulations
Safety of Human Cells, Tissues and organs for transplantation Regulations
To Schedule F: Pre-notifications
Project 1670 Addition of Velaglucerase alfa to Schedule F (April 13, 2011)
Project 1670 Addition of Trabectedin, its salts and derivatives to Schedule F (April
13, 2011)
Project 1670 Addition of Roflumilast, its salts and derivatives to Schedule F (April
13, 2011)
Project 1670 Addition of Pazopanib and its salts to Schedule F (April 13, 2011)
Project 1670 Addition of Liraglutide and its salts to Schedule F (April 13, 2011)
Project 1670 Addition of Exenatide and its salts to Schedule F (April 13, 2011)
OCP Bylaw No. 2 – December 2010 s
Schedule A: Code of Ethics for members
Schedule B: “Code of Conduct” and Procedures for Council and Committee
members.
References
OCP Required Reference Guide for Pharmacies in Ontario, March, 2011
* Information available at Publications Ontario (416) 326-5300 or 1-800-668-9938 www.e-laws.gov.on.ca
** Information available at www.napra.org
' Information available at Federal Publications Inc. Ottawa: 1-888-4FEDPUB (1-888-433-3782)
Toronto: Tel: (416) 860-1611 • Fax: (416) 860-1608 • e-mail: info@fedpubs.com
s Information available at www.ocpinfo.com
PHARMACY CONNECTION ~ SPRING 2011 ~ PAGE 59